ESGH 10-K & 10-Q changes, risk factors and insider trading
ESG Inc. · OTC · Agricultural Production-Crops · CIK 1883835 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
Removed heading “Risks Related to the Market for our Stock”
Removed heading “The OTC and share value”
Largest changes
“Although substantially all of our operations are conducted in China through our subsidiaries, we are a Nevada corporation and our current independent registered public accounting firm is Tang Qian & Associates, PLLC, a Texas-based PCAOB-registered accounting firm engaged on February 18, 2026. Nevertheless, changes in U.S. or PRC law, regulation, inspection access, data-transfer restrictions, or the cross-border audit environment could adversely affect our reporting obligations, financing activities, and the market for our securities.”see in full comparison
Our PRC subsidiaries have not opened HPF accounts for their employees (almost all of them are with rural housing registration).see in full comparisonRegardingWiththoserespect to employeeswhofor whom our PRC subsidiaries do not make HPFno contribution to HPF,contributions, our PRC subsidiaries have entered into employmentcontractsarrangementswith themintended to clarifysalarythat compensation includes an amount in lieu of such contributions and that the employees are responsible for their own related housing arrangements. However, these arrangements may not be sufficient toincludeeliminatecontributiontheandriskemployee hasthatobligation to deal with it by themself. Although ourthe PRC subsidiariesdo this way, they may still potentiallycould beorderedrequired byHPFtheenforcementrelevant authorities to make fullcontribution,HPF contributions and could facelitigationemployeebyclaimsemployeesorinotherrelationproceedings relating totheirsuchfailure to make full contribution.contributions. As of the date of this report, our PRC subsidiaries have not received any demand or order from the competent authorities with respect to their HPF contribution. To the extent the PRC subsidiaries are required to make such payments, our financial condition will likely be adversely affected.
Temperature can have a significant impact on the growth and the quality of mushrooms. Although our growing facilities are indoors and operated undersee in full comparisonthemonitoredcontrol of AI monitor,environmental controls, wearemay stillpotentialexperiencetomalfunctionsencounter the malfunction ofin cooling, airflow,andor heating system.
Our farms aresee in full comparisonresponsiblerequiredfortocomplyingcomply withtheapplicable legal and regulatory requirements.It is possible thatIf we fail to comply withanyPRClawlaws relating to foodsafetysafety, composting,duringcultivation or related operations, thecompostingrelevantand growing. If thegovernmentalagencyauthoritiesdeterminescouldwerequireare not eligibleus tocontinuesuspend or modify operations. In addition, theoperation, we will need to pause. Our farms may also be negatively impacted by badquality of our raw materialssomayfailaffect our ability tocomply withmeet our internal qualitystandards.standards and applicable regulatory requirements.
Full comparison: every changed paragraph (14)
Our primary business activities have historically focused on fresh white button mushrooms products although we began a fresh mushroom processing business in the fourth quarter of 2024. Because our focus has historically been limited in this way, any risk affecting the fresh mushrooms industry or consumers’ desire for fresh mushrooms products could disproportionately affect our business. To enhance our ability to continue to operate, we are dedicating resources to generate recurring revenues and sustainable operating cash flows. On December 31, 2022, AUM, a subsidiary of ESG acquired 12 mushroom houses by assuming debt. The new operations further increase the production of mushrooms and reduce fixed cost per unit to reach the scale effect of economics. On January 5, 2022, Funan Agricultural Reclining Investment Co. Ltd signed an agreement to fund $18.09 million by 10-year debt financing for the expansion of composting facilities, which will further generate revenue on compost sales with a higher profit margin. In 2024, we improved efficiency with current facilities, the revenue of fresh mushroom reached USD 5.86 million and the processing revenue of fresh mushroom reached USD 3.94 million, respectfully; on the other side, we were expanding our composting facilities to generate compost sale revenue of USD 2.88 million in 2024. In 2025, the revenue was USD 4.58 million due to the suspension of production in the fourth quarter.
Our PRC subsidiaries have not opened HPF accounts
for their employees (almost all of them are with rural housing registration). RegardingWith thoserespect to employees whofor whom our PRC subsidiaries do not make HPF
no contribution to HPF,contributions, our PRC subsidiaries have entered into employment contractsarrangements with themintended to clarify salarythat compensation includes an amount
in lieu of such contributions and that the employees are responsible for their own related housing arrangements. However, these arrangements
may not be sufficient to includeeliminate contributionthe andrisk employee
hasthat obligation to deal with it by themself. Although ourthe PRC subsidiaries do this way, they may still potentiallycould be orderedrequired by HPFthe enforcement
relevant authorities to make full contribution,HPF contributions
and could face litigationemployee byclaims employeesor inother relationproceedings relating to theirsuch failure to make full contribution.contributions. As of
the date of this report, our PRC subsidiaries have not received any demand or order from the competent authorities with respect to their
HPF contribution. To the extent the PRC subsidiaries are required to make such payments, our financial condition will likely be adversely
affected.
Temperature can have a significant impact on
the growth
and the quality of mushrooms. Although our growing facilities are indoors and operated under themonitored control of AI monitor,environmental
controls, we aremay still potentialexperience tomalfunctions encounter
the malfunction ofin cooling, airflow, andor heating
system.
Our
farms are responsiblerequired forto complyingcomply with theapplicable legal
and regulatory requirements. It is possible thatIf we fail to comply with any PRC lawlaws relating to food safetysafety,
composting, duringcultivation or related operations, the compostingrelevant and growing. If the
governmental agencyauthorities determinescould werequire are not eligibleus to continuesuspend or modify operations.
In addition, the operation, we will need to pause. Our farms may also be negatively
impacted by bad quality of our raw materials somay failaffect our ability to comply withmeet our internal quality standards.standards and applicable regulatory
requirements.
An insufficient amount ofInsufficient insurance coverage could expose
us to significant costs and
business disruption.
An emerging growth company is also exempt from
Section Section
404(b) of the Sarbanes OxleySarbanes-Oxley Act, which requires that the registered accounting firm shall, in the same report, attest to and
report on
the assessment on the effectiveness of the internal control structure and procedures for financial reporting. Similarly, as
a Smaller
Reporting Company we are exempt from Section 404(b) of the Sarbanes-OxleySarbanes- Oxley Act and our independent registered public accounting
firm will
not be required to formally attest to the effectiveness of our internal control over financial reporting until such time as
we cease being
a Smaller Reporting Company.
We would
will cease to be an emerging growth company upon
the earliest of:
Although substantially all of our operations are conducted in China through our subsidiaries, we are a Nevada corporation and our current independent registered public accounting firm is Tang Qian & Associates, PLLC, a Texas-based PCAOB-registered accounting firm engaged on February 18, 2026. Nevertheless, changes in U.S. or PRC law, regulation, inspection access, data-transfer restrictions, or the cross-border audit environment could adversely affect our reporting obligations, financing activities, and the market for our securities.
Movements in Renminbi exchange rates are affected
by, among other things,
changes in political and economic conditions and China’s foreign exchange regime and policy. The Renminbi
has been unpegged from the U.S. dollar since July 2005 and, althoughAlthough the People’s Bank of
China regularly intervenes in the
foreign exchange market to limit fluctuations in Renminbi exchange rates, the Renminbi may appreciate
or depreciate significantly in value
against the U.S. dollar in the medium to long term. Moreover, it is possible that the PRC authorities
may lift restrictions on fluctuations
in Renminbi exchange rates and lessen intervention in the foreign exchange market in the future.
Under the current PRC tax regulations, indirect
transfers transfers
of equity interests and other properties of PRC tax resident enterprises by non-PRCnon- PRC holding companies may be subject to PRC
tax. In accordance
with the Announcement of the State Administration of Taxation on Several Issues concerning the Enterprise Income Tax
on the Indirect Transfers
of Properties by Non-Resident Enterprises (“Announcement 7”) issued by the SAT on February 3, 2015,
if a non-PRC tax
resident enterprise indirectly transfers equities and other properties of a PRC tax resident enterprise and such indirect
transfer will
produce a result identical or substantially similar to direct transfer of equity interests and other properties of the PRC
tax resident
enterprise, the non-PRC tax resident enterprise may be subject to PRC withholding tax at a rate up to 10%. The Announcement
of the State
Administration of Taxation on Matters Concerning Withholding of Income Tax of Non-resident Enterprises at Source (“Announcement
37”), which was issued by SAT on October 17, 2017, and became effective on December 1, 2017, renovates the principles
and procedures
concerning the indirect equity transfer tax withholding for a non-PRC tax resident enterprise. Failure to comply with the
tax payment
obligations by a non-PRC tax resident will result in penalties, including full payment of tax owed, fines and default interest
on those
tax.
The SAFE’s Circular on Reforming the Administration
Approach Regarding the Foreign Exchange Capital Settlement of Foreign-investedForeign- invested Enterprises (“Circular 19”) provides that
the the
conversion from foreign currency registered capital of foreign-invested enterprises into the Renminbi capital may be at foreign-invested
enterprises’ discretion, which means that the foreign currency registered capital of foreign-invested enterprises for which the
rights and interests of monetary contribution has been confirmed by the local foreign exchange bureau (or the book-entry of monetary contribution
has been registered) can be settled at the banks based on the actual operational needs of the enterprises.
Risks Related to the Market for our Stock
The OTC and share value
Risks Related to the Market f or our Stock The OTC
and share value Our Common Stock trades over the counter, which
may may
deprive stockholders of the full value of their shares. Our stock is quoted via the Over-The-Counter (“OTC”) Pink Sheets
under under
the ticker symbol “ESGH”. Therefore, our Common Stock is expected to have fewer market makers, lower trading volumes,
and and
larger spreads between bid and asked prices than securities listed on an exchange such as the New York Stock Exchange or the NASDAQ
Stock Stock
Market. These factors may result in higher price volatility and less market liquidity for our Common Stock.
Management's Discussion & Analysis (MD&A)
Largest changes
“Subsequent to year-end, the Company also completed additional financing transactions and entered into strategic licensing arrangements, which management believes may assist liquidity and support future business development; however, there can be no assurance that such actions will be sufficient to address the Company’s near-term capital requirements.”see in full comparison
“Revenues decreased to $6,122,633 for the year ended December 31, 2025 from $12,682,330 for the year ended December 31, 2024, a decrease of $6,559,697, or 51.7%. The decrease was primarily attributable to the suspension and disruption of production during 2025, including production losses associated with the construction and implementation of environmental protection and EPA-compliance related facilities, which adversely affected compost quality and output and caused the Company to decide the suspension of production. …”see in full comparison
“As a direct consequence of the disruption, the Company experienced a substantial decline in revenue and incurred an operating loss for the three months ended September 30, 2025. The adverse impact on composting in August rendered certain production batches unusable, leaving insufficient usable compost to sustain the cultivation of mushrooms in the latter part of the quarter. Notably, the Company did not record any fresh mushroom sales in September 2025, as the harvest that would normally have occurred in that month was lost due to the compromised compost. …”see in full comparison
“The third quarter of 2025 was marked by significant operational disruptions related to the Company’s ongoing environmental compliance and capacity expansion initiatives. In particular, the Company undertook the construction and installation of a new Environmental Protection Agency (“EPA”) compliance facility and related integration equipment at its primary production site. This project stems from an approved Environmental Impact Assessment (EIA) and associated local regulatory obligations, requiring the Company to upgrade its facilities to meet enhanced environmental standards. …”see in full comparison
“Management took decisive action in response to these challenges. Subsequent to the end of the quarter, in late October 2025, the Company temporarily suspended production operations at its primary facility to facilitate the swift completion of the EPA compliance facility installation and to prevent further losses. …”see in full comparison
Net cash provided (used) in financing activities weresee in full comparison$1,031,380$888,777 and$344,354,$1,031,380, respectively for the year ended December 31,20242025 and2023.2024. The Company paid off $97,394 and $134,854 of loan, and borrowed $1,121,025 for the year ended December 31, 2025. The Company made payments of debts of $8,010,030 and long-term payable ofof$293,064, borrowed $7,271,714 of loans for the year ended December 31,2024, comparing to $7,045,131 of loan and $7,389,485 of payment made for the year ended December 31, 2023.2024.
Full comparison: every changed paragraph (22)
ESG Inc. (“ESG”) was incorporated
in in
July 2021, a Nevada corporation and headquartered at KennettChadds Square,Ford, Pennsylvania, USA, and is a holding company to develop and operate
operate sustainable plant based ingredients and food production and distribution with the planned expansion into the food
related business with
the substantial experience of its management team, the board of directors including expertise and
relationships in the industry of mushroom,
agriculture and food in the world and the capital markets in the States.
Financial Condition
The third quarter of 2025 was marked by significant operational disruptions related to the Company’s ongoing environmental compliance and capacity expansion initiatives. In particular, the Company undertook the construction and installation of a new Environmental Protection Agency (“EPA”) compliance facility and related integration equipment at its primary production site. This project stems from an approved Environmental Impact Assessment (EIA) and associated local regulatory obligations, requiring the Company to upgrade its facilities to meet enhanced environmental standards. The construction activities during the quarter adversely impacted the Company’s normal production process – most notably the mushroom composting conditions in August 2025 – which in turn had a material negative effect on our financial results for the period.
As a direct consequence of the disruption, the Company experienced a substantial decline in revenue and incurred an operating loss for the three months ended September 30, 2025. The adverse impact on composting in August rendered certain production batches unusable, leaving insufficient usable compost to sustain the cultivation of mushrooms in the latter part of the quarter. Notably, the Company did not record any fresh mushroom sales in September 2025, as the harvest that would normally have occurred in that month was lost due to the compromised compost. This absence of September sales, combined with lower production volumes in August, significantly reduced the Company’s quarterly revenue relative to prior periods. In contrast, the Company’s operating costs – including fixed overhead and ongoing expenses continued to be incurred, which resulted in a negative impact on profitability for the quarter.
Management took decisive action in response to these challenges. Subsequent to the end of the quarter, in late October 2025, the Company temporarily suspended production operations at its primary facility to facilitate the swift completion of the EPA compliance facility installation and to prevent further losses. This decision was made after careful consultation with internal management and external experts, reflecting management’s determination that a short-term halt in production was the most prudent course to expedite project completion and ensure full compliance with environmental requirements. While this production suspension occurred after September 30, 2025, and it is an important development that influenced negatively the Company’s near-term operations and the results of operation.
Revenues decreased to $6,122,633 for the year ended December 31, 2025 from $12,682,330 for the year ended December 31, 2024, a decrease of $6,559,697, or 51.7%. The decrease was primarily attributable to the suspension and disruption of production during 2025, including production losses associated with the construction and implementation of environmental protection and EPA-compliance related facilities, which adversely affected compost quality and output and caused the Company to decide the suspension of production. As a result, the Company experienced reduced availability of compost, reduced fresh mushroom production, and reduced processed mushroom powder available for sale. Cost of goods sold decreased to $5,605,113 in 2025 from $9,134,997 in 2024; however, gross profit decreased to $517,520 from $3,547,333 primarily due to the significant decline in production and sales volume and the under-absorption of fixed operating costs during the production disruption.
The net operating revenue were $12,682,330 for
the year ended December 31, 2024, compared to $7,452,129 of net operating revenues for the year ended December 31, 2023, an increase of
$5,230,201, or 70.2%.
The increase was due to the expanded capacity
and sale on Phase III compost as well as the production and export sale of the seasoning powder from the processed mushroom.
Cost of goods sold was $9,134,997$5,605,113 for the year
ended December 31, 2024,2025, compared to $5,697,351$9,134,997 of cost of goods sold for the year ended December 31, 2023,2024, ana increasedecrease of $3,437,646$3,529,884 or
or 60.3%.38.6%.
The expansion of triple capacity completed, and the Company underwent operational
testing of the expanded facility in 2024. The increase was due to the increased input for the expanded capacity along with the increase in sales.
Gross profit margin is a ratio calculated by dividing
gross profit
by net operating revenues. Our gross profit margin increaseddecreased to 28.0%8.5% for the year ended December 31, 2024,2025, compared to 23.5% 28.0%
for the
year ended December 31, 2023.2024. The increasedecrease was primarily due to the increasedecrease of scale margin from the expansion of capacity. Fixed costs such as depreciation expense spread over more products along with the expanded production scale resulted
in a decrease in unit cost.margin.
During the year ended December 31, 2024,2025, Research and development expenses
increaseddecreased $99,012,$346,242, or 16.2%48.9% versus the prior year. In 2024, Research and development input increased.
For the year ended December 31, 2024, 2025,
selling, general and administrative
expenses decreasedincreased $203,822,$1,253,605, from $1,150,927 to $2,404,532, or 15.0%102% versus the prior year. The decrease
increase in administrative expenses was mainly due to cuttingthe expenditures
andwrite-ff improvingof efficiency.the scrap of raw materials.
For the year ended December 31, 2025, interest expense was $524,722, compared to $653,114 for the year ended December 31, 2024, a decrease of $128,392, or 19.7%. The decreases were primarily due to the impact of fluctuation of currency exchange rate.
For the year ended December 31, 2024, interest expense was $653,114,
compared to $413,165 for the year ended December 31, 2023, an increase of $239,949, or 58.1%. The increases were primarily due to the
impact of interest accrued from loans and asset acquisition in 2024. (Refer to Note 12 – ASSET ACQUISITION)
NetOther income was $271,073 for the year ended December
31, 2025 compared to $213,315 for the year ended December 31, 2024 compared
to $230,635 for the year ended December 31, 2023,2024, an decreaseincrease of $17,320,$57,758, or 7.5%.27.1%. The decrease in other income was
primarily due to the
decrease of government grants.
The Company recorded no income taxes for the year ended December 31, 2024,
and 2023, respectively. AUM2025, and AUMT2024, are exempt from income tax and AUFP had operating loss for the year ended December 31, 2024 and 2023.respectively.
Net cash provided by operating activities for
the year ended December
31, 2025 and 2024 and 2023 was $1,546,524$101,246 and $119,934,$1,546,524, respectively, ana increasedecrease of $1,426,588$1,445,278 or 1189.5%.93.5%. This increase decrease
was primarily due to the
increase decrease of revenue.
Net cash used in investing activities for the
year ended December 31,
2024 2025 and 20232024 were $685,056$178,227 and $0,$685,056, respectively. The Company purchased $685,056 of machinery equipment for the year
ended December
31, 2025 and 2024.
Net cash provided (used) in financing activities
were $1,031,380$888,777 and $344,354,
$1,031,380, respectively for the year ended December 31, 20242025 and 2023.2024. The Company paid off $97,394 and $134,854 of
loan, and borrowed $1,121,025 for the year ended December 31, 2025. The Company made payments of debts of $8,010,030 and long-term payable
of of
$293,064, borrowed $7,271,714 of loans for the year ended December 31, 2024, comparing to $7,045,131 of loan and $7,389,485 of payment
made for the year ended December 31, 2023.2024.
Our long-term debt obligations as of December
31, 2025 and 2024 were $1,095,690. $152,550 was included in accrued expenses$960,836 and other$1,095,690, current labilities as current portion of long-term
liabilities and expected to be paid within 12 months.respectively. Our long-term debt obligation are related to assets acquisition. See Note
11, 11
Assets Acquisition and Note 12, Long-term Payable, to the consolidated financial statements included in Part II, Item 8, Financial
Statements.
Subsequent to year-end, the Company also completed additional financing transactions and entered into strategic licensing arrangements, which management believes may assist liquidity and support future business development; however, there can be no assurance that such actions will be sufficient to address the Company’s near-term capital requirements.
What changed in the latest 10-Q
Risk Factors
As a smaller reporting company, the Company is not required to provide the information required by this Item.
Largest changes
“As a smaller reporting company, the Company is not required to provide the information required by this Item. There have been no material changes from the risk factors disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, except that investors should consider the Company’s continuing liquidity constraints, suspension of PRC operations, proposed split-off of China operations and early-stage North America product commercialization plans.”see in full comparison
“As a smaller reporting company, the Company is not required to provide the information required by this Item.”see in full comparison
Full comparison: every changed paragraph (2)
As a smaller reporting company, the Company is not required to provide the information required by this Item.
As a smaller reporting company, the Company is not required to provide
the information required by this Item. There have been no material changes from the risk factors disclosed in the Company’s Annual
Report on Form 10-K for the year ended December 31, 2025, except that investors should consider the Company’s continuing liquidity
constraints, suspension of PRC operations, proposed split-off of China operations and early-stage North America product commercialization
plans.
Management's Discussion & Analysis (MD&A)
New heading “Professional Fees”
New heading “Loss from Continuing Operations and Net Loss”
New heading “Financing Activities”
Removed heading “Comparison of the three months ended March 31, 2026 and 2025”
Removed heading “Off-Balance Sheet Arrangements”
Removed heading “Recently Issued Accounting Pronouncements”
Largest changes
“Management’s plans include seeking additional debt or equity financing, negotiating extensions, conversions or modifications of outstanding debt, controlling operating expenses, commercializing the Company’s North American products and evaluating strategic transactions. Financing may not be available when required or on acceptable terms. Failure to obtain financing or generate sufficient operating cash flow could require the Company to delay product launches, reduce operations, default on obligations or pursue a restructuring or other strategic transaction.”see in full comparison
“The Company’s continuing operations generated only $918 of revenue during the six months ended June 30, 2026 and have not generated sufficient cash flow to fund operating expenses, public-company costs, working-capital requirements and debt obligations. Existing cash and expected operating cash flows are not expected to be sufficient to meet the Company’s obligations for the twelve months following issuance of the financial statements. These conditions raise substantial doubt about the Company’s ability to continue as a going concern, and management’s plans have not alleviated that doubt.”see in full comparison
“Interest expense was $26,036 and $32,817 for the three and six months ended June 30, 2026, respectively, compared with no interest expense during the corresponding 2025 periods. The 2026 expense resulted from the Company’s convertible notes, including stated interest and amortization of debt discounts and approximately $13,110 of additional default interest recognized during the second quarter of 2026 under the Labrys Fund II, L.P. convertible promissory note. See Note 6 to the unaudited condensed consolidated financial statements.”see in full comparison
“Loss from continuing operations was $27,283 for the three months ended June 30, 2026, compared with $96,074 for the corresponding 2025 period, as revised. For the six months ended June 30, 2026, loss from continuing operations was $175,137, compared with $213,615 for the corresponding 2025 period, as revised. The 2026 losses included interest expense associated with the Company’s convertible notes, including the additional default interest recognized under the Labrys note described above.”see in full comparison
“As of March 31, 2026, the Company had cash of $206,391 and a working capital deficiency of approximately $6.9 million. Current liabilities included $6.2 million of short-term bank loans, $475,000 of convertible notes payable, $1.6 million of accounts payable, $110,590 of current deferred income and $5.3 million of accrued expenses and other current liabilities. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.”see in full comparison
Full comparison: every changed paragraph (56)
You should read the following discussion and analysis together with
the unaudited condensed consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q and the audited
consolidated consolidated
financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended
December 31,
2025.
This Quarterly Report on Form 10-Q contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regardingregarding, among
other matters, our
plans, objectives, expectations, financing and liquidity needs, operating strategy, possiblethe anticipated effects of the
completed split-off of our China operations, North America productthe development and
commercialization, commercialization of our North American food products, and other future events. These statements are based on current expectations
events and assumptions and involve risks and uncertainties.
Actual results may differ materially from those expressed or implied by forward-looking statements. We undertake no obligation to update
forward-looking statements except as required by law.circumstances.
Forward-looking statements are based on management’s current expectations, estimates, assumptions and projections and are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such statements. Readers should not place undue reliance on these forward-looking statements. Except as required by applicable law, the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
On May 26, 2026, the Company completed the split-off of its China operations pursuant to the Split-Off and Share Exchange Agreement described in Note 4 to the unaudited condensed consolidated financial statements. In connection with the transaction, the Company transferred its ownership of ESG China Limited and its subsidiaries, and 10,432,800 shares of the Company’s common stock were surrendered and canceled. The former China operations ceased to be consolidated effective May 26, 2026 and are presented as discontinued operations for all periods presented.
Following the split-off, the Company’s continuing operations consist of its early-stage North American food and snack business conducted through ESG Provisions, Inc. The Company is developing and commercializing mushroom-based snacks and alternative-protein products through product development, sourcing, packaging, co-manufacturing, e-commerce and other commercialization activities.
The continuing business generated limited revenue during the six months ended June 30, 2026 and remains dependent on additional financing, successful product commercialization, third-party suppliers and manufacturers, production readiness, supply-chain execution and customer acceptance.
ESG Inc. is a Nevada holding company. Historically, the Company conducted
substantially all operations through PRC subsidiaries engaged in mushroom composting, cultivation and processing. During the three months
ended March 31, 2026, the PRC mushroom operations remained suspended and generated no revenue. The suspension, together with liquidity
constraints and supplier payable matters, materially affected the Company’s results of operations and cash flows.
The Company is pursuing a strategic repositioning toward North America
food operations, including mushroom-based snacks and alternative protein products through ESG Provisions, Inc. In the first quarter of
2026, the Company entered into financing transactions with Monroe Street Capital Partners, LP and Crom Structured Opportunities Fund I,
LP and completed a limited conversion of accrued interest and fees under the Labrys note.
After quarter-end, the Company entered into a Split-Off and Share Exchange
Agreement relating to its China operations, as described in Note 14. As of March 31, 2026, the Company continued to consolidate the China
operations. Because the proposed split-off was entered into after quarter-end and had not closed as of March 31, 2026, the China operations
are not presented as held for sale or discontinued operations in this Quarterly Report. The Company expects to reassess the presentation
in future reporting periods if and when the transaction satisfies the applicable accounting criteria.
Comparison of the three months ended March 31, 2026 and 2025
Revenue
For the three months ended March 31, 2026, the Company generated no
revenue, compared to revenue of $1,587,144 for the three months ended March 31, 2025. The decrease was primarily due to the suspension
of the PRC mushroom operations during the 2026 period.
Revenue, Cost of Goods Sold and Gross Profit
Revenue from continuing operations was $918 for both the three and six months ended June 30, 2026, compared with no revenue during the corresponding 2025 periods.
Cost of goods sold was $555 for both the three and six months ended June 30, 2026, resulting in gross profit of $363 and a gross margin of approximately 39.5%. The continuing business remains in an early commercialization stage, and the results are not necessarily indicative of future periods.
Cost of goods sold was $0 for the three months ended March 31, 2026,
compared to $1,506,212 for the three months ended March 31, 2025. Gross profit was $0 for the three months ended March 31, 2026, compared
to $80,932 for the 2025 period. The decrease was consistent with the absence of revenue during the 2026 period.
Selling, general and administrative expenses increased by $497,751
or 172.0%, to 787,081 for the three months ended March 31, 2026 from $289,330 for the three months ended March 31, 2025. The increase
was primarily attributable to the classification of depreciation expense related to property, plant and equipment as selling, general
and administrative expense during the suspension of production operations, together with public company and administrative costs.
Research and Development Expenses
ResearchSelling, general and developmentadministrative expenses were $0$1,610 for the three
months ended
March 31,June 30, 2026, compared towith $66,323$96,074 for the comparablecorresponding 2025 period, dueas torevised. The decrease of $94,464, or approximately
98.3%, principally reflected $90,559 of share-based compensation included in the suspensionrevised 2025 period and the limited level of researchcontinuing
operations andduring testing activities related to
the PRC2026 operations.quarter.
For the six months ended June 30, 2026, selling, general and administrative expenses were $126,863, compared with $193,115 for the corresponding 2025 period, as revised. The 2026 amount included $95,939 of share-based compensation attributable to the three months ended March 31, 2026. The 2025 amount included $181,119 of revised share-based compensation.
On June 1, 2026, the Company issued 115,908 restricted shares in settlement of $540,035.48 of compensation earned through March 31, 2026. The issuance did not result in additional second-quarter expense and had no effect on cash flows. See Note 7.
Professional Fees
Professional fees were $0 and $15,820 for the three and six months ended June 30, 2026, respectively, compared with $0 and $20,500 for the corresponding 2025 periods. The six-month decrease of $4,680 primarily reflected the timing of legal, accounting, audit and other professional services.
Interest expense was $26,036 and $32,817 for the three and six months ended June 30, 2026, respectively, compared with no interest expense during the corresponding 2025 periods. The 2026 expense resulted from the Company’s convertible notes, including stated interest and amortization of debt discounts and approximately $13,110 of additional default interest recognized during the second quarter of 2026 under the Labrys Fund II, L.P. convertible promissory note. See Note 6 to the unaudited condensed consolidated financial statements.
Loss from Continuing Operations and Net Loss
Loss from continuing operations was $27,283 for the three months ended June 30, 2026, compared with $96,074 for the corresponding 2025 period, as revised. For the six months ended June 30, 2026, loss from continuing operations was $175,137, compared with $213,615 for the corresponding 2025 period, as revised. The 2026 losses included interest expense associated with the Company’s convertible notes, including the additional default interest recognized under the Labrys note described above.
Loss from discontinued operations was $46,206 and $878,342 for the three and six months ended June 30, 2026, respectively. Income from discontinued operations was $701,917 and $452,745 for the corresponding 2025 periods.
Consolidated net loss was $73,489 and $1,053,479 for the three and six months ended June 30, 2026, respectively, compared with consolidated net income of $605,843 and $239,130 for the corresponding 2025 periods, as revised.
Interest expense decreased by $7,391, or 5.7%, to $123,011 for the
three months ended March 31, 2026 from $130,402 for the three months ended March 31, 2025.
Other Income
Other income decreased by $102,927, or 79.8%, to $26,043 for the three
months ended March 31, 2026 from $128,970 for the three months ended March 31, 2025, primarily due to reduced government grant and subsidy
income.
Net Loss
Net loss was $884,050 for the three months ended March 31, 2026, compared
to $276,153 for the three months ended March 31, 2025. Net loss attributable to ESG Inc. was $682,214 for the three months ended March
31, 2026, compared to $212,664 for the three months ended March 31, 2025.
As of June 30, 2026, the Company had cash of $161,100, current assets of $190,745 and current liabilities of $564,916, resulting in a working-capital deficit of $374,171. Current liabilities included accounts payable of $64,324, accrued interest payable of $19,522 and convertible notes payable, net, of $481,070. The aggregate outstanding principal of the convertible notes was $495,000.
The Company’s continuing operations generated only $918 of revenue during the six months ended June 30, 2026 and have not generated sufficient cash flow to fund operating expenses, public-company costs, working-capital requirements and debt obligations. Existing cash and expected operating cash flows are not expected to be sufficient to meet the Company’s obligations for the twelve months following issuance of the financial statements. These conditions raise substantial doubt about the Company’s ability to continue as a going concern, and management’s plans have not alleviated that doubt.
Management’s plans include seeking additional debt or equity financing, negotiating extensions, conversions or modifications of outstanding debt, controlling operating expenses, commercializing the Company’s North American products and evaluating strategic transactions. Financing may not be available when required or on acceptable terms. Failure to obtain financing or generate sufficient operating cash flow could require the Company to delay product launches, reduce operations, default on obligations or pursue a restructuring or other strategic transaction.
Cash Flows
As of March 31, 2026, the Company had cash of $206,391 and a working
capital deficiency of approximately $6.9 million. Current liabilities included $6.2 million of short-term bank loans, $475,000 of convertible
notes payable, $1.6 million of accounts payable, $110,590
of current deferred income and $5.3 million of accrued expenses and other current liabilities. These conditions raise substantial doubt
about the Company’s ability to continue as a going concern.
The Company does not believe that its existing cash will be sufficient
to fund operations and obligations for the next twelve months. The Company will need additional financing through debt, equity or strategic
transactions. Financing may not be available on acceptable terms, or at all, and may involve dilution, restrictive covenants or other
limitations.
Cash Flows from Operating Activities
Net cash used in operating activities was $708,659 for the three months
ended March 31, 2026, compared to $1,625,425 for the three months ended March 31, 2025. The decrease in cash used was primarily attributable
to lower accounts payable reductions for the three months ended March 31, 2026.
Cash Flows from Investing Activities
Net cash used in investingoperating activities was $0$57,847 for the threesix months
ended ended
MarchJune 31,30, 2026, compared towith $88,321$1,531,277 for the threecorresponding months ended March 31, 2025. The decrease was due to no purchases of property, plant
and equipment during the 20262025 period.
Continuing operations used $84,905 of cash during the six months ended June 30, 2026, compared with $40,992 during the corresponding 2025 period. The 2026 reconciliation included a noncash share-based compensation adjustment of $95,939.
Discontinued operations provided $27,058 of cash during the six months ended June 30, 2026 and used $1,490,285 during the corresponding 2025 period.
Cash Flows from FinancingInvesting Activities
Continuing operations had no investing cash flows during either period. Discontinued operations had no investing cash flows during the six months ended June 30, 2026 and used $208,253 during the corresponding 2025 period.
Financing Activities
Continuing operations received $200,000 of net financing cash flows during the six months ended June 30, 2026 from the Monroe and Crom convertible-note financings. Continuing operations had no financing cash flows during the corresponding 2025 period.
Discontinued operations had no financing cash flows during the six months ended June 30, 2026 and provided $1,341,253 during the corresponding 2025 period.
The Company transferred $38,493 of cash and restricted cash in connection with the China split-off and recorded a $22,431 adverse effect of exchange-rate changes on cash and restricted cash. Cash and restricted cash increased by $81,229, from $79,871 at December 31, 2025 to $161,100 at June 30, 2026.
Net cash provided by financing activities was $200,000 for the three
months ended March 31, 2026, compared to $1,416,723 for the three months ended March 31, 2025. During the 2026 period, the Company received
$200,000 in aggregate gross proceeds from convertible note financings.
Off-Balance Sheet Arrangements
The Company had no off-balance sheet arrangements as of March 31, 2026
that management believes are reasonably likely to have a current or future material effect on the Company’s financial condition
or results of operations.
Recently Issued Accounting Pronouncements
Management continues to evaluate recently issued accounting standards,
including ASU 2024-03 relating to disaggregation of income statement expenses and ASU 2023-09 relating to income tax disclosures. The
Company does not expect these standards to have a material impact on its financial statements upon adoption, although they may require
additional disclosures.
ESGH insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding ESGH (13F)
None of the 59 investors we track reported a position in their latest 13F.